Mittal Ruchi R, Manokaran Ranjith Kumar, James Saji
Department of Paediatrics, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
Department of Paediatric Neurology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India.
J Pediatr Neurosci. 2021 Jan-Mar;16(1):69-70. doi: 10.4103/jpn.JPN_68_20. Epub 2021 Jun 25.
Pyridoxine-dependent epilepsy is a treatable cause of epilepsy, which is very well known. It is most commonly caused by mutations in and genes. A 5-month-old infant presented with refractory seizures. Magnetic resonance imaging (MRI) brain was normal. Clinical exome sequencing showed a novel mutation in gene. He responded very well to pyridoxine and has been seizure free since the beginning of the treatment. gene mutations have been recently described as a cause for pyridoxine-dependent epilepsy. Here, we describe a first case report of mutation from India with a rare genetic variant presenting as pyridoxine-dependent epilepsy.
吡哆醇依赖性癫痫是一种已知的可治疗的癫痫病因。它最常见由[具体基因1]和[具体基因2]基因的突变引起。一名5个月大的婴儿出现难治性癫痫发作。脑部磁共振成像(MRI)正常。临床外显子组测序显示[具体基因3]基因有一个新突变。他对吡哆醇反应良好,自治疗开始后一直无癫痫发作。[具体基因3]基因突变最近已被描述为吡哆醇依赖性癫痫的一个病因。在此,我们报告了印度首例[具体基因3]突变导致吡哆醇依赖性癫痫的病例,该病例呈现一种罕见的基因变异。